Merit Medical EP Group Announces Launch of HeartSpan® Steerable Sheath Introducer

Merit Medical continues to add to its extensive line of products for Electrophysiology. The HeartSpan Steerable Sheath Introducer offers control, coverage and comfort for Electrophysiologists when navigating cardiac chambers. The 8.5F HeartSpan Steerable Sheath Introducer’s braided construction provides kink resistance and curve durability. The distal tapered tip creates a smooth transition from the dilator to sheath introducer to reduce trauma to the atrial septum.

CONTROL 

  • Softer, flexible tip
  • Smooth transition from dilator
  • Responsive curve deflection
  • Braided construction for kink resistance

COVERAGE 

  • Bidirectional (180-degree) deflection
  • Small curl (16.4 mm)
  • Medium curl (22.4 mm)
  • Large curl (36.0 mm)

COMFORT 

  • Ergonomic shape
  • Improved grip size

The HeartSpan line of products also includes the HeartSpan® Fixed Curve Braided Transseptal Sheath with braided steel shaft for excellent torqueability and the HeartSpan® Transseptal Needle designed to be exceptionally responsive with enhanced stiffness.

Our EP team is excited to introduce this new steerable sheath designed to help EPs extend their options.

Merit Offers Radial Internal Mammary Catheter for Navigating LIMA Grafts

Transradial cardiac catheterization in patients with previous coronary artery bypass graft surgery can be technically challenging.

Impress

Since the majority of CABG patients have a left internal mammary artery (LIMA) graft to the left anterior descending artery (LAD), many radial operators choose to perform catheterization procedures in CABG patients from a left radial approach using standard femoral diagnostic catheters. However, other operators have reported success with the right radial access to the LIMA. Right radial access for right radial LIMA angiography provides more comfortable access from the right side of the patient, reduces back strain, and the need to reach over the patient, especially patients who are obese.

For patients with LIMA grafts, Merit Medical now offers a Radial Internal Mammary catheter to facilitate navigation to the left internal mammary from the right transradial approach. The Merit Radial Internal Mammary catheter is available in 4F and 5F, 110 cm lengths. The Impress® material offers a highly torqueable shaft with a soft, tapered atraumatic tip.

Combining Merit’s broad offering of products for radial approach with your clinical expertise can help achieve the improved outcomes you expect from the radial approach including reduced complications, quicker ambulation, and increased patient comfort.

For more information about the Impress Radial Internal Mammary catheter and Merit’s growing portfolio of products for your radial procedures, visit the product page on merit.com.

Tami Anderson
Senior Product Manager

Malagari Safety and Efficacy Study of HCC TACE with HepaSphere™ Microspheres 30-60µm

Malagari photo of doc

Dr. Katerina Malagari et al conducted a study of 45 patients with hepatocellular carcinoma (HCC) treated with the new 30-60 µm size HepaSphere Microspheres. The study found that “TACE with HepaSphere was well tolerated with an acceptable safety profile and no 30-day mortality.”1 The overall objective response from the study was “(CR + PR), including patients treated at all dosages of doxorubicin, was seen in 68.9% of cases.”1 The results were published in Cardiovascular Interventional Radiology in February 2014.

HepaSphere 30–60 µm is a new size of a loadable microsphere that has a dry caliber of 30–60 µm that expands to 166–242 (197 ± 31) µm in saline and 145–213 (148 ± 45) µm after loading with doxorubicin. HepaSphere Microspheres’ unique properties offer the following advantages:

Targeted:       Flow directed due to spherical shape.

Absorbing:     Rapidly absorbs aqueous solutions such as contrast media, saline, or reconstituted doxorubicin HCI.*

Conforming: Compresses in the vessel lumen, providing more surface contact with vessel intima.

Expanding:    Expands up to four times the stated dry diameter when hydrated.

HepaSphere Microspheres are indicated for use in embolisation of blood vessels with or without delivery of doxorubicin HCl for therapeutic or preoperative purposes in the following procedures: Embolisation of hepatocellular carcinoma and embolisation of metastases to the liver. For full prescribing information, please refer to the HepaSphere Microspheres Instructions for Use.

Antonio Rivera
Senior Product Manager
1 Malagari K, Pomoni M, Moschouris H, Kelekis A, et al. Chemoembolization of hepatocellular carcinoma with Hepasphere 30-60 . Safety and efficacy study. Cardiovasc Intervent Radiol. 2014 Feb;37:165-175.

HepaSphere Microspheres is a Class III Device, CE 0459, and manufactured for Merit Medical Systems, Inc. by Biosphere Medical, S.A., Parc des Nations-Paris Nord 2, 383 rue de la Belle Etoile, 95700 Roissy en France. HepaSphere Microspheres are not approved or available for sale in the United States.

Next Generation of the Merit Snares iPad® App Is Now Available

I am pleased to announce the availability of the next generation Merit Snares for iPad. This app is designed to help customers when selecting the appropriate EN Snare® or ONE Snare® product configuration for use in a desired vessel. The app also provides the technical product code specifications for reference and ordering purposes.

Interested in downloading Merit Snares for iPad? You can download it from the App Store via the following link: https://itunes.apple.com/us/app/merit-snares/id951074703?ls=1&mt=8

Designed with accuracy and reliability in mind, the ONE Snare and the EN Snare Endovascular Snare Systems go hand-in-hand to provide physicians with both single loop and triple loop options to help meet clinically-challenging case that may arise.

Jesse Hansen
Director of Marketing